NMPA-2021-0024-V024

Major variation for application NMPA-2021-0024. Major variation: New Dosage Strength for Semaglutidex — major revision

Variation Number
NMPA-2021-0024-V024
Type
Major
Application
NMPA-2021-0024
Change
CHG-2021-0024
Status
Failed
Fee
€65,217
Submitted
—
Approved
—
Description

Major variation: New Dosage Strength for Semaglutidex — major revision